SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-209169
Filing Date
2009-10-16
Accepted
2009-10-16 17:04:14
Documents
3
Period of Report
2009-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15857
2 PRESS RELEASE dex991.htm EX-99.1 9379
3 GRAPHIC g77800ex99_1pg1.jpg GRAPHIC 14687
  Complete submission text file 0001193125-09-209169.txt   47291
Mailing Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134
Business Address 220 MIRACLE MILE SUITE 234 CORAL GABLES FL 33134 (305) 529-2522
Catalyst Pharmaceutical Partners, Inc. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 091123969
SIC: 2834 Pharmaceutical Preparations